Literature DB >> 10586226

Molecular mechanisms for CMT1A duplication and HNPP deletion.

C F Boerkoel1, K Inoue, L T Reiter, L E Warner, J R Lupski.   

Abstract

As the best characterized human genomic disorders, CMT1A and HNPP illustrate several common mechanistic features of genomic rearrangements. These features include the following: (1) Recombination occurs between homologous sequences flanking the duplicated/deleted genomic segment. (2) The evolution of the mammalian genome may result in an architecture consisting of region-specific low-copy repeats that predispose to rearrangement secondary to providing homologous regions as substrate for recombination. (3) Strand exchange occurs preferentially in a region of perfect sequence identity within the flanking repeat sequences. (4) Double-strand breaks likely initiate recombination between the flanking repeats. (5) The mechanism and rate of homologous recombination resulting in DNA rearrangement may differ for male and female gametogenesis. (6) Homologous recombination resulting in DNA rearrangement occurs with high frequency in the human genome. (7) Genomic disorders result from structural features of the human genome and not population specific alleles or founder effects; therefore, genomic disorders appear to occur with equal frequencies in different world populations.

Entities:  

Mesh:

Year:  1999        PMID: 10586226

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  A rheostat model for a rapid and reversible form of imprinting-dependent evolution.

Authors:  Arthur L Beaudet; Yong-Hui Jiang
Journal:  Am J Hum Genet       Date:  2002-04-24       Impact factor: 11.025

2.  2002 Curt Stern Award Address. Genomic disorders recombination-based disease resulting from genomic architecture.

Authors:  James R Lupski
Journal:  Am J Hum Genet       Date:  2003-02       Impact factor: 11.025

3.  Serial segmental duplications during primate evolution result in complex human genome architecture.

Authors:  Pawełl Stankiewicz; Christine J Shaw; Marjorie Withers; Ken Inoue; James R Lupski
Journal:  Genome Res       Date:  2004-11       Impact factor: 9.043

4.  The evolutionary chromosome translocation 4;19 in Gorilla gorilla is associated with microduplication of the chromosome fragment syntenic to sequences surrounding the human proximal CMT1A-REP.

Authors:  P Stankiewicz; S S Park; K Inoue; J R Lupski
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

Review 5.  Molecular genetics of autosomal-dominant demyelinating Charcot-Marie-Tooth disease.

Authors:  Henry Houlden; Mary M Reilly
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

6.  Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.

Authors:  D E Jenne; S Tinschert; H Reimann; W Lasinger; G Thiel; H Hameister; H Kehrer-Sawatzki
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

7.  Structure and evolution of the Smith-Magenis syndrome repeat gene clusters, SMS-REPs.

Authors:  Sung-Sup Park; Paweł Stankiewicz; Weimin Bi; Christine Shaw; Jessica Lehoczky; Ken Dewar; Bruce Birren; James R Lupski
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

8.  Identification of a 3.0-kb major recombination hotspot in patients with Sotos syndrome who carry a common 1.9-Mb microdeletion.

Authors:  Remco Visser; Osamu Shimokawa; Naoki Harada; Akira Kinoshita; Tohru Ohta; Norio Niikawa; Naomichi Matsumoto
Journal:  Am J Hum Genet       Date:  2004-11-16       Impact factor: 11.025

9.  The 1.4-Mb CMT1A duplication/HNPP deletion genomic region reveals unique genome architectural features and provides insights into the recent evolution of new genes.

Authors:  K Inoue; K Dewar; N Katsanis; L T Reiter; E S Lander; K L Devon; D W Wyman; J R Lupski; B Birren
Journal:  Genome Res       Date:  2001-06       Impact factor: 9.043

Review 10.  Clinical and Molecular Aspects of MBD5-Associated Neurodevelopmental Disorder (MAND).

Authors:  Sureni V Mullegama; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2016-05-25       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.